Veradermics (MANE) closed at $125.64 on November 17, 2026, down 1.9% from the previous close, on volume of 393,109 shares (30-day average 799,633).
Data as of November 17, 2026.
17-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 21, 2026 | Call Spread | 20-Nov-26160 : 180 C | 1,000 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 17, 2026. See the largest for 5, 30, 60 and 90 days
TipRanks (Mon, 16-Nov 6:30 AM ET)
Veradermics, Incorporated (MANE) Receives a Buy from Leerink Partners
TipRanks (Fri, 13-Nov 9:40 AM ET)
Veradermics to Present at the Jefferies Global Healthcare Conference in London
Business Wire (Thu, 12-Nov 4:30 PM ET)
Business Wire (Tue, 10-Nov 7:30 AM ET)
Business Wire (Mon, 9-Nov 7:00 AM ET)
Business Wire (Sun, 8-Nov 6:00 PM ET)
MANE rallies after Phase 3 Study '304' shows early Month 2 separation and up to 36.4 hairs/cm gain
Market Chameleon (Mon, 19-Oct 7:41 AM ET)
Business Wire (Mon, 19-Oct 7:00 AM ET)
Business Wire (Sun, 18-Oct 6:00 PM ET)
Veradermics to Present at Upcoming September Investor Conferences
Business Wire (Thu, 3-Sep 5:33 PM ET)
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Veradermics trades on the NYSE stock market under the symbol MANE.
As of November 17, 2026, MANE stock price declined to $125.64 with 393,109 million shares trading.
MANE has a beta of 0.15, meaning it tends to be less sensitive to market movements. MANE has a correlation of 0.00 to the broad based SPY ETF.
MANE has a market cap of $5.30 billion. This is considered a Mid Cap stock.
The top ETF exchange traded funds that MANE belongs to (by Net Assets): VTI, IWM, VXF, SCHA, JGRO.
MANE support price is $121.60 and resistance is $134.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MANE shares will trade within this expected range on the day.